Michael Burry recent buys & sells (2025 Q3)
Scion Asset Management
Scion Asset Management Portfolio Changes
Purchase & sale details
- Portfolio value:
- $68.14M (+$12M)
- Previous value:
- $56.25M
- # of changes:
- 9
- New positions:
- 3
- Reported for:
- 30 Sep 2025 (Q3)
- Latest filing date:
- 03 Nov 2025
Scion Asset Management has disclosed a total of 9 changes to the portfolio in the latest (2025 Q3) SEC report(s): increased the number of shares of 1, bought 3 totally new and completely sold out 5 position(s).
What stocks is Michael Burry buying now?
In the recent quarter Michael Burry has purchased 4 securities: (MOH) Molina Healthcare Inc (new buy), (LULU) Lululemon Athletica Inc (added shares +100.00%), (SLM) SLM Corp (new buy) and (BRKR 6.375 09.01.28) BRUKER CORP (new buy).
What does Michael Burry invest in?
Michael Burry's holdings are (MOH) Molina Healthcare Inc (35.11%), (LULU) Lululemon Athletica Inc (26.11%), (SLM) SLM Corp (19.50%) and (BRKR 6.375 09.01.28) BRUKER CORP (19.28%).
In the latest report(s) the following changes have been made to the investments: (MOH) Molina Healthcare Inc (new buy), (LULU) Lululemon Athletica Inc (added shares +100.00%), (SLM) SLM Corp (new buy) and (BRKR 6.375 09.01.28) BRUKER CORP (new buy).
9 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BRUKER CORP
|
new
|
+48,334
|
48,334
|
+19.28%
|
$271.80
|
|
19.28%
|
2025 Q3
|
~0.25 years
|
|
|
|
Molina Healthcare Inc
|
new
|
+125,000
|
125,000
|
+35.11%
|
$191.36
|
+8.17%($207.00)
|
35.11%
|
2025 Q3
|
~0.25 years
|
|
|
|
SLM Corp
|
new
|
+480,054
|
480,054
|
+19.5%
|
$27.68
|
-20.77%($21.93)
|
19.50%
|
2025 Q3
|
~0.25 years
|
|
|
|
Lululemon Athletica Inc
|
+100.00%
|
+50,000
|
100,000
|
+13.06%
|
$177.93
|
-45.28%($97.36)
|
26.11%
|
2025 Q2
|
~0.50 years
|
|
|
|
UnitedHealth Group Incorporated
|
-100%
|
-20,000
|
0
|
-11.09%
|
$311.97
|
+28.84%($401.95)
|
0.00%
|
2025 Q2
|
~0.25 years
|
|
|
|
Regeneron Pharmaceuticals Inc
|
-100%
|
-15,000
|
0
|
-14%
|
$525.00
|
+50.49%($790.05)
|
0.00%
|
2025 Q2
|
~0.25 years
|
|
|
|
Estee Lauder Companies Inc
|
-100%
|
-150,000
|
0
|
-21.55%
|
$80.80
|
+30.25%($105.24)
|
0.00%
|
2024 Q4
|
~0.75 years
|
|
|
|
MercadoLibre Inc
|
-100%
|
-3,000
|
0
|
-13.94%
|
$2,613.63
|
-30.16%($1,825.26)
|
0.00%
|
2025 Q2
|
~0.25 years
|
|
|
|
Bruker Corp
|
-100%
|
-250,000
|
0
|
-18.31%
|
$41.20
|
+33.33%($54.93)
|
0.00%
|
2025 Q2
|
~0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".